Global Neurodiagnostics Market Size study & Forecast, by Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics) by End Use (Hospitals & Clinics) and Regional Forecasts 2022-2032

Description

The Global Neurodiagnostics Market, valued at approximately USD 18.21 billion in 2024, is anticipated to grow at a steady CAGR of 3.80% between 2025 and 2035, reaching nearly USD 27.45 billion by the end of the forecast period. Neurodiagnostics, encompassing a wide array of technologies such as neuroimaging, in vitro diagnostics, and neuroinformatics, has evolved into an indispensable pillar of modern healthcare. It facilitates early detection, precise monitoring, and personalized treatment planning for a spectrum of neurological disorders, including Alzheimer's disease, epilepsy, Parkinson's disease, and multiple sclerosis. The rise in neurological disease prevalence, coupled with an aging global population and growing patient awareness, is amplifying the demand for advanced neurodiagnostic solutions. This heightened awareness, bolstered by continuous medical research and rapid technological progress, has positioned the market for sustained expansion over the next decade.

The increasing integration of AI and machine learning into neurodiagnostic platforms is redefining how clinicians interpret complex neurological data, enabling faster and more accurate diagnoses. Moreover, the surging demand for non-invasive and minimally invasive diagnostic procedures is pushing innovation in imaging modalities such as MRI, CT, PET, and EEG, as well as in advanced molecular and biomarker-based assays. According to recent healthcare studies, neurological disorders are among the top causes of disability worldwide, and their economic burden continues to escalate-driving both public and private sectors to invest heavily in cutting-edge diagnostic infrastructures. However, high equipment costs, limited access to advanced facilities in low- and middle-income countries, and the shortage of trained neuro-specialists may impede growth in certain regions, necessitating strategic collaborations to bridge these gaps.

North America currently holds a dominant share of the global neurodiagnostics market, driven by its robust healthcare infrastructure, high adoption rate of advanced imaging systems, and a strong presence of market-leading medical device companies. The United States, in particular, benefits from significant R&D funding, a large base of neurologists, and a high incidence of neurological conditions that necessitate regular diagnostic testing. Europe follows closely, with countries like Germany, France, and the UK leveraging well-established healthcare systems and government-backed research programs to promote innovation in neurodiagnostic solutions. The Asia Pacific region is expected to witness the fastest growth during the forecast period, supported by rising healthcare investments in China, India, and Japan, growing medical tourism, and the rapid expansion of specialized neurology centers. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as promising markets, propelled by improving healthcare access, increased awareness campaigns, and the adoption of tele-neurology in underserved areas.

Major market players included in this report are:

GE Healthcare
Siemens Healthineers AG
Canon Medical Systems Corporation
Philips Healthcare
Nihon Kohden Corporation
Natus Medical Incorporated
F. Hoffmann-La Roche Ltd
Hitachi Medical Systems
Medtronic plc
Compumedics Limited
Lifelines Neuro Company, LLC
Advanced Brain Monitoring, Inc.
Electrical Geodesics, Inc. (EGI)
Masimo Corporation
Micromed S.p.A.

Global Neurodiagnostics Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Technology:

Neuroimaging Technologies
In Vitro Diagnostics
Neuroinformatics

By End Use:

Hospitals & Clinics

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Neurodiagnostics Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study (Historical Data - 2023, 2024; Base Year - 2024; Forecast period - 2025-2035)

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Neurodiagnostics Market Forces Analysis

3.1. Market Forces Shaping The Global Neurodiagnostics Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of neurological disorders and ageing population driving demand for diagnostics
- 3.2.2. Integration of AI/machine learning and demand for non-invasive, high-throughput diagnostic solutions
3.3. Restraints
- 3.3.1. High capital expenditure and operational costs limiting adoption in certain markets
- 3.3.2. Limited access to advanced facilities and shortage of trained neuro-specialists in low- and middle-income countries
3.4. Opportunities
- 3.4.1. Tele-neurology, remote diagnostics and point-of-care deployments expanding addressable markets
- 3.4.2. Growing investments and infrastructure expansion in Asia Pacific and emerging markets; AI-enabled platform commercialization

Chapter 4. Global Neurodiagnostics Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Neurodiagnostics Market Size & Forecasts by Technology 2025-2035

5.1. Market Overview
5.2. Global Neurodiagnostics Market Performance - Potential Analysis (2025)
5.3. Neuroimaging Technologies
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. In Vitro Diagnostics
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Neuroinformatics
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Neurodiagnostics Market Size & Forecasts by End Use 2025-2035

6.1. Market Overview
6.2. Global Neurodiagnostics Market Performance - Potential Analysis (2025)
6.3. Hospitals & Clinics
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Other End-Users (if applicable)
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Neurodiagnostics Market Size & Forecasts by Region 2025-2035

7.1. Neurodiagnostics Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Neurodiagnostics Market
- 7.3.1. U.S. Neurodiagnostics Market
  - 7.3.1.1. Technology breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Neurodiagnostics Market
  - 7.3.2.1. Technology breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End-use breakdown size & forecasts, 2025-2035
7.4. Europe Neurodiagnostics Market
- 7.4.1. UK Neurodiagnostics Market
  - 7.4.1.1. Technology breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Neurodiagnostics Market
  - 7.4.2.1. Technology breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.3. France Neurodiagnostics Market
  - 7.4.3.1. Technology breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Neurodiagnostics Market
  - 7.4.4.1. Technology breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Neurodiagnostics Market
  - 7.4.5.1. Technology breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Neurodiagnostics Market
  - 7.4.6.1. Technology breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End-use breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Neurodiagnostics Market
- 7.5.1. China Neurodiagnostics Market
  - 7.5.1.1. Technology breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.2. India Neurodiagnostics Market
  - 7.5.2.1. Technology breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Neurodiagnostics Market
  - 7.5.3.1. Technology breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Neurodiagnostics Market
  - 7.5.4.1. Technology breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Neurodiagnostics Market
  - 7.5.5.1. Technology breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Neurodiagnostics Market
  - 7.5.6.1. Technology breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End-use breakdown size & forecasts, 2025-2035
7.6. Latin America Neurodiagnostics Market
- 7.6.1. Brazil Neurodiagnostics Market
  - 7.6.1.1. Technology breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Neurodiagnostics Market
  - 7.6.2.1. Technology breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End-use breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Neurodiagnostics Market
- 7.7.1. UAE Neurodiagnostics Market
  - 7.7.1.1. Technology breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Neurodiagnostics Market
  - 7.7.2.1. Technology breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End-use breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Neurodiagnostics Market
  - 7.7.3.1. Technology breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End-use breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. GE Healthcare
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Siemens Healthineers AG
8.4. Canon Medical Systems Corporation
8.5. Philips Healthcare
8.6. Nihon Kohden Corporation
8.7. Natus Medical Incorporated
8.8. F. Hoffmann-La Roche Ltd.
8.9. Hitachi Medical Systems
8.10. Medtronic plc
8.11. Compumedics Limited
8.12. Lifelines Neuro Company, LLC
8.13. Advanced Brain Monitoring, Inc.
8.14. Electrical Geodesics, Inc. (EGI)
8.15. Masimo Corporation
8.16. Micromed S.p.A.